Oncology & Cancer

Few high-grade soft tissue sarcoma patients receive chemo

(HealthDay)—The rates of adults with high-grade soft tissue sarcoma (STS) who receive chemotherapy may be lower than expected, indicating a need for more aggressive systemic treatments, according to a study published in ...

Oncology & Cancer

New evidence supports surgery for rare type of brain lymphoma

Through a systematic review of published studies going back 50 years, Johns Hopkins Medicine researchers say they have identified a distinct subtype of primary central nervous system (PCNS) lymphoma that should be considered ...

Oncology & Cancer

Neoadjuvant chemotherapy key to survival in pancreatic cancer

(HealthDay)—Three factors can predict survival in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 2 in the Annals of ...

Surgery

More frequent surveillance no benefit after NSCLC resection

(HealthDay)—For patients undergoing resection for non-small cell lung cancer (NSCLC), more frequent surveillance is not associated with improved survival, according to a study published in the October issue of the Annals ...

Neuroscience

Medial temporal lobe surgery linked to prevalence of tinnitus

(HealthDay)—Patients with epilepsy undergoing medial temporal lobe (MTL) surgery have increased prevalence of tinnitus compared with controls and participants with self-reported epilepsy (SRE), according to a research letter ...

Oncology & Cancer

ASCO updates recs on potentially curable pancreatic cancer

(HealthDay)—Guidelines relating to the appropriate adjuvant regimen for patients with pancreatic cancer have been updated in light of new evidence, according to a special article published online April 11 in the Journal ...

page 5 from 8